OLIVIA GACHOMO: Open Payments
NPI 1942690359 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$232 in 4 payments from 3 companies in 2025. Trend: 2023 $15 · 2024 $33 · 2025 $232
Food & beverage: $232
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 1 | $123 |
| ACADIA Pharmaceuticals Inc | 1 | $71 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
Products named: UZEDY, NUPLAZID, REXULTI.
Industry payments across TX — which companies pay providers there.
